Femiguard
Retrievable Fallopian Tube Occlusion Device
StartupFemiguard is a Ra'anana-based startup in the Health Tech & Life Sciences sector, established in 2020. Retrievable Fallopian Tube Occlusion Device. Femiguard was founded by Shlomi Cohen. Key investors include Sanara Ventures. The company has 1-10 employees.
The company follows a B2B business model. Product stage: Clinical Trial.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQRa'anana
- Last RoundUndisclosed
- Sanara VenturesLead
Shlomi CohenCo-founder & CMO
What does Femiguard do?
Femiguard offers a safe and effective solution for infertile women diagnosed with hydrosalpinx as well as for women seeking reversible nonhormonal contraception. The Feminity device is specifically designed to block the ostium of the fallopian tube, preventing the spillage of undesired fluids into the uterine cavity and resulting in increased IVF implantation rates. The device’s unique shape and structure is also designed to accommodate periodic contractions of the uterus and fallopian tubes.
Who founded Femiguard?
Femiguard was founded in 2020 by Shlomi Cohen (Co-founder & CMO).
What sector is Femiguard in?
Femiguard operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Consumers, Demographics & Family, Women.
Where is Femiguard located?
Femiguard is based in Zarhin St 13, Ra'anana, Israel.